Studies have successfully combined transcriptomic and proteomics findings to provide mechanistic insights, such as the finding of lysosomal changes in Grn-/- mice that are modulated by the FTD-risk protein TMEM106B (Klein et al., 2017). The gene discussed is TMEM106B; the disease is frontotemporal dementia.